H 202 Vermont House · 2025-2026 Regular Session

An act relating to increasing the transparency of prescription drug costs and spending

This bill increases transparency around prescription drug costs in Vermont. It prohibits pharmacy benefit managers from requiring patients to pay more than the drug's average cost plus a standard dispensing fee (based on Vermont Medicaid rates). Pharmacies must post notices informing patients about available price options, including cash prices. Hospitals must report annual details about their participation in the federal 340B drug discount program to the Green Mountain Care Board, and health insurers must send patients annual reports showing actual drug spending on their behalf. These requirements directly affect patients, pharmacies, insurers, and healthcare providers.
Bill status introduced 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 12, 2025 Last action Feb 12, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Feb 12, 2025
Introduced
Read first time and referred to the Committee on Health Care
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Mari Cordes
Mari Cordes
DDemocratic/Progressive
VT
Addison-4